期刊文献+

结肠癌中RHAMM与ERK2的表达及其与临床病理特征的关系 被引量:2

Expressions of RHAMM and ERK2 and their correlations with clinical pathological characteristics in colon cancer
下载PDF
导出
摘要 目的:探讨透明质酸介导运动的受体(receptor for hyaluronan-mediated motility,RHAMM)和ERK2(extracellular signal-regulated kinase)在结肠癌组织中表达及其与临床病理因素的关系,评估其在结肠癌诊断及预后中的价值。方法:收集我院结肠癌患者标本30例及其相应癌旁组织,通过real-timePCR对RHAMM和ERK2进行检测。结果:RHAMM和ERK2在结肠癌组织较癌旁组织表达均明显升高(P<0.001),且两者表达在低分化、中分化和高分化3组组间差异无显著性(P=0.222和P=0.173),但都与是否发生淋巴结转移有关(P=0.01和P<0.001);两者表达具有一定相关性(P=0.009,r=0.465)。结论:结肠癌中的RHAMM和ERK2表达都高于正常组织,且两者表达有相关性,RHAMM可能通过Ras-ERK途径参与了结肠癌的发生、进展及转移,RHAMM和ERK2可作为患者诊断和预后的参考指标之一。 Objective To investigate the expressions of receptor for hyaluronan-mediated motility(RHAMM)and extracellular signal-regulated kinase(ERK2)and their correlations with clinical pathological factors of colon cancer,and to evaluate their value in diagnosis and prognosis of colon cancer.Methods Real-time PCR was used to detect the expressions of RHAMM and ERK2 in 30 colon cancer tissues and 30 matched tumor-adjacent samples.Results The expressions of RHAMM and ERK2 in tumor tissues were significantly higher than those in tumor-adjacent samples(P 0.001),and were not associated with tumor differentiation(P = 0.222 and P = 0.173,respectively),but were associated with lymph node metastasis(P = 0.01 and P 0.001,respectively).There was significant correlation between the expressions of RHAMM and ERK2(r = 0.465,P = 0.009).Conclusion The expressions of RHAMM and ERK2 are higher in colon cancer than those in tumor-adjacent samples,and they are correlated to each other.Which suggest that RHAMM may involve in the pathogenesis and metastasis of colon cancer through Ras-ERK pathway.Expressions of RHAMM and ERK2 may be helpful in the diagnosis and prognosis of colon cancer.
出处 《实用医学杂志》 CAS 北大核心 2011年第10期1760-1762,共3页 The Journal of Practical Medicine
关键词 结肠肿瘤 RHAMM ERK2 realtime-PCR Colonic neoplasms RHAMM ERK2 Real time-PCR
  • 相关文献

参考文献4

  • 1周道平,胡斌.实时荧光定量PCR对早期结肠癌的诊断价值[J].实用医学杂志,2010,26(11):2021-2022. 被引量:4
  • 2Deschoolmeester V,Baay M,Specenier P,et al.A review ofthe most promising biomarkers in colorectal cancer:one stepcloser to targeted therapy[J].Oncoioom,2005,7(15):699-731.
  • 3Zlobec I,Baker K,Minoo P,et al.Node-negative eoloreetalcancer at hi[gh risk of distant metastasis identified by combinedanalysis of lymph node status,v88culsr invasion,and Raf-1kinase inhibitor protein expression[J].Clin Cancer Res,2008,1(14):143-148.
  • 4Lugi A,Zlobee I,Gunthert U,et al.Overexpression ofthereceptor for hyaluronic acid mediated motility is an independentadverse prognostic factor in colorectal cancer[J].Mod Pathol.2006,10(19):1302-1309.

二级参考文献9

  • 1Shoji Y, Dohke M, Masuda T, et al. Solitary adrenal metastasis in a patient with sigmoid colon cancer, report of a case [J]. Int J Gastrointest Cancer, 2006,37(4):120-123.
  • 2Ho C H, Yu Y B, Wu P H. The prevalence of iron deficiency anemia and its clinical implications in patients with colorectal carcinoma[J]. J Chin Med Assoc, 2008,71(3):119-122.
  • 3Thomas S N, Zhu F, Schnaar R L, et al. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow [J]. J Biol Chem, 2008,283(23): 15647-15655.
  • 4Aoki S, Takagi Y, Hayakawa M, et al. Detection of peritoneal mierometastases by reverse transcriptase polymerase chain reaction targeting eareinoembryonie antigen and eytokeratin 20 in colon cancer patients[J]. J Exp Clin Cance Res, 2002,21 (4) :555-562.
  • 5Wyld D K, Selby P, Perren T J, et al. Detection of coloreetal cancer cells in peripheral blood by reverse transcriptase polymerase chain reaction for cytokeratin 20 [J]. Int J Cancer, 1998,79(3) : 288-293.
  • 6Nanashima A, Shibata K, Nakayama T, et al. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma [J]. Ann Surg Oncol, 2009, 16(8):2130-2137.
  • 7Castells A, Boix L, Bessa X, et al. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction [J].Br J Cancer, 1998,78(10) : 1368-1372.
  • 8周贤友,梁玉娣,熊秀莲,陈惠文.CA724、CEA和C-反应蛋白定量联合检测对诊断胃肠道恶性肿瘤的临床价值[J].现代医院,2009,9(7):74-75. 被引量:12
  • 9林国乐,邱辉忠,徐彤,钱家鸣.大肠癌患者术前和术中外周血微转移的检测及其临床意义[J].中华普通外科杂志,2002,17(10):605-607. 被引量:8

共引文献3

同被引文献61

  • 1张淑卿,郝凤娟,项茂林.老年人大肠癌术后早期肠内营养的应用及护理[J].山东医药,2005,45(34):78-78. 被引量:1
  • 2唐镇,韩英.左半结肠肿瘤并急性肠梗阻一期肠切除治疗体会[J].中华普通外科杂志,2006,21(3):232-232. 被引量:6
  • 3王谦,孙启龙,王传新,张建业,王洪春,杨晓静.CK20 mRNA和hTERT mRNA在大肠癌围手术期血行微转移中的转录特征[J].临床检验杂志,2006,24(6):409-412. 被引量:2
  • 4Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, La Farina M, Albanese I, Dardanoni G, Salerno S, Tomasino RM, Labianca R, Gebbia N, Russo A. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are as- sociated with mucinous histotype. Ann Oncol 2002; 13:1438-1446.
  • 5Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A. Clinical relevance of EGFR- and KRAS- status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. Cancer Treat Rev 2009; 35:262-271.
  • 6Markman B, Javier Ramos F, Capdevila J, Tabernero J. EGFR and KRAS in colorectal cancer. Adv Clin Chem 2010; 51:71-119.
  • 7Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:1626-1634.
  • 8Yen LC, Uen YH, Wu DC, Lu CY, Yu FJ, Wu IC, Lin SR, Wang JY. Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab. Ann Surg 2010; 251:254-260.
  • 9Maxwell CA, Keats JJ, Belch AR, Pilarski LM, Reiman T. Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res 2005; 65:850-860.
  • 10Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 1998; 111(Pt 12): 1685-1694.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部